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STUDIES ON CAPILLARY PERMEABILITY USING COOMASSIE
BLUE AS INDICATOR*
FREDERICK KALZ, M.D. AND ZOLTAN FEKETE, M.D.
\\Te recently reported on the use of a pro-
tein dye, Coomassie blue (1), as an indicator of
leakage of plasma proteins from the capillaries.
This dye is useful for studying alterations in
capillary permeability and for a more accurate
characterization of whealing responses in the
human skin. We found an excellent correlation
between the area and degree of bluing, and the
varying concentrations of wlseal producing test
substances. Consistent and reproducible results
were obtained in any individual test subject, thus
providing a method for investigating the influ-
ence of drugs and other agents on the capillary
pcrmeability of the human skin.
The present paper reports the results ot such
an investigation; experiments were conducted to
study the effects of histamine release and block-
ing substances and of some other drugs on the
bluing response elicited by several test agents. It
was felt that additional insight in the mechanism
of capillary permeability could be gained and a
skin test could be developed for measuring or
comparing the efficacy of anti-inflammatory
drugs.
MATEEIALS AND METHODS
The following wheal producing substances in
the amounts shnwn were used to produce an
increase in capillary permeability:
g per inj.
Histamine Acid Phos-
phate (British Drug
House) 100 10 1 0.1 0.01
Compound 48-80 (Bur-
roughs Welleome). .. 100 10 1 0.1 0.01
Polymyxin B. sul-
phate (Burroughs
Welleome) 500 50 5 0.5 0.05
5-HT (Serotonin)
(Mann Research
Laboratories) 1000 500 100 50 10
Trypsin (Frank W.
Homer) 500 50 5 0.5 0.05
* From the Section of Dermatology, Depart-
ment of Medicine, Royal Victoria Hospital and
McGill University, Moutreal, Canada.
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The test subtances were dissolved in physio-
logical saline and a volume of 0.1 ml was injected
intradermally with a 25 gauge needle. The range
of concentration was chosen after preliminary
testing to establish the minimal amount of each
test substance which still produced a bluing
response. The lowest concentration of each com-
pound represents the minimal amount and the
other concentrations were arbitrarily selected, to
give comparable intensity of whealing with all
test substances. 125 volunteers served as test
subjects, most of them were healthy individuals
or had trivial disorders. A demarcated area of the
back was chosen for all experiments, the right
side served as test site and the corresponding left
side was used as control area in the series of clec-
trophoretie applications. The 5 injections of each
substance representing the indicated amounts
were spaced approximately 5 cm. apart, starting
with the lowest concentration on the bottom of
the field followed by the others in increasing order.
Preliminary experiments had established that the
responses did not vary significantly within this
circumscribed area of the skin. Immediately before
the intradermal injections, 400 mgms of Coomassic
blue were given intravenously; 5 minutes after
the intradermal injections the size of the wheals
and flares was measured and the intensity of the
bluing was recorded by color photography under
standard conditions. (Kodak Pony camera for
medical photography, 2 one thousand Watt lamps,
20 inches distance, No. 5 adaptation lens, 5.6
aperture, 3f0 sec. exposure. Kodachrome Type A
prof. negative).
Drugs Administered by Mouth Prior to Repent
Testing
(9'yproheptndine (Prep. MK 147 Merck) 1 mgm 4
times daily.
This substance has a marked anti-serotonin and
anti-histamine effect (2).
Promethazine Hydrochtoride (Phenergan, Poutenc)
25 mgms 6 times daily (10 experiments).
A phenothiazine derivative with anti-histaminic
and anti-scrotonin properties as well as with
local anaesthetic action (20 experiments).
Tripetennamine hydrochtoride (Pyribenzamin Gibe)
50 mgms 4 times daily.
Presented at the Twenty-first Annual Meeting
of The Society for Investigative Dermatology,
Inc., Miami Beach, Florida, June 13, 1060.
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A drug with anti-histaminic properties (3, 4)
(10 experiments).
Corticosteroids. Dexamethasone (Decadron
Merck) 0.75 mgms 4 times daily. Triameinolon
(Aristocort, Lederle) 4 mgms 4 times daily. 36-
Methyl prednisolone) Medrol, Upjohn) 4 mgms 4
times daily (8 experiments).
In addition 2 patients were tested wao had re-
ceived high dosage of corticosteroids for a pro-
longed period of time. (One suffering from
pemphigus, one from an erythroderma.)
Drugs Introduced Locally into the Skin
by Means af lantophoresis
A. Blocking substances.
Cyproheptadine (see above). 0.2% aqueous
solution (10 eases).
Promethazine (see above). 1% aqueous solu-
tion (10 eases).
B. Release substances.
Compound 48-80, a condensation product of
p- ,ethoxyphenethylmethylamine and form-
aldehyde, a substance causing depletion of
mast cells, liberating histamine and heparin
and, in most animal species, serotonin. 0.1%
aqueous solution (5, 6) (20 eases).
Polymyxin B. Sulphate, an antibiotic which
is also a potent histamine liberator. 0.2%
aqueous solution (7) (10 cases).
C. Other Compounds
Histamine phosphate. 0.1% aqueous solution
(10 cases).
Procaine hydrochloride. 4% aqueous solution
(8 cases).
Metanium (Leeming Miles) a mixture of
titanium salts, (oxyde, peroxyde, salieylate
and tannate) a substance reputed to have
anti -inflammatory properties. Saturated
aqueous solution (10 cases).
Fm. 1. Normal reactions to histamine phos-
phate, trypsin and polymixine B sulphate. The
test substances were given intradermally in a
tenfold serial dilution, the largest amount in-jected on the top, the smallest on the bottom.
D. Control
Sodium chloride, 2% solution (S cases).
The iontophoresis was carried out by means of a
7.5 x 12.5 cm. electrode, using 0.32 mA electric
current for 15 minutes, except for histamine when
only 0.16 mA was used for 10 minutes. Metanium
and sodium chloride were applied from both the
cathode and the anode, while in all other instances
the effective component of the drug, or releasing
substance, could be introduced only from the
anode. In one series of experiments the ionto-
phoretic applications were done only once and the
intradermal test injections were given 30 minutes
after the completion of the ionization. In a second
Fia. 2. Normal reactions to intradermal histamine phosphate and to trypsin.
Fm. 3. Same patient as on Fig. 2. after 7 days treatment with cyproheptadine tablets (4 mgms daily
by mouth): no wheals and bluing to intradermal histamine phosphate, reactions to trypsin is unaltered
Flares persist.
Fm. 11. Metanium iontophoresis (saturated solution in water, from the anode, right side of the pic-
ture) inhibited all the reactions to intradermal serotonin, but had no effect on the reactions to histamine
phosphate.
no. 12. On the right side of the back sodium chloride, 2.0% solution in water, was iontophorised
from kathode (sodium ion driven in). Intradermally injected test substances: polymixine B sulphate
and histamine phosphate. The reactions are identical on both sides.
Fso. 13. Extravasation of coomassie blue produced by the iontophoresis of histamine phosphate,
0.1% solution in water, for 10 minutes from the anode. Picture taken 30 minutes after the ionisation.
flu. 16. Result of iontophoresis with sodium chloride, 2.0% solution in water, from the anode (chlo-
ride ion driven in). No bluing, only some redness. Picture taken 30 minutes after the ionisation.
flu. 17. On the forearm of a patient with cold uritcaria, a piece of ice was applied for 2 minutes. At
the start of the exposure to ice, coomassie blue was injected intravenously in the other arm. This proce-
dure resulted in erythema, elevation and bluing on the site of the ice-exposure.
flu. 18. Same patient as on fig. 17. The same test was repeated after one week's treatment with
cyproheptadine tablets (4 mgms daily by mouth). The erythematous response is unchanged, hardly any
elevation and bluing.
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TABLE 1
The effect of the single and/or repeated iontophoresis of histamine, compound 48-80, polymixine B sul-
phate, cyproheptadine, promethazine, sodium chloride on the wheals and bluing provoced by intrader-
mat injections of histamine phosphate, serotonin, compound 48-80, polymixine B sulphate and
trypsin.
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series the iontophoresis was repeated 3 times in
the same area at intervals of 3 hours and the in-
tradermal testing was done 24 and 48 hours after
the last ionization.
The right side of the back was used for the ionto-
phoresis in all cases, the left side remained un-
treated to serve as control; the intradermal test
injections were given in corresponding areas on
both sides.
RESULTS
1. Response and bluing to intradermal test sub-
stances
The intradermal injections of histamine phos-
phate and of the two release substances resulted
in spreading wheals surrounded by flares. The
wheals showed marked bluing while the flares
remained unstained.
Serotonin produced large flares but only small,
flat wheals, which showed bluing even in con-
centrations as low as 10 micrograms.
Trypsin caused larger wheals with intensive
bluing but only insignificant flares. (Fig. 1)
Physiological saline was used as control in-
jection and never showed bluing in normal skin.
2. Effect of oral administration of drugs on the
bluing reaction
Cyproheptadine, in the dosage used, prevented
wheal formation and bluing of all test substances
in all amounts used, except for the reactions to
trypsin which remained unaltered. The axon
reflex flares caused by histamine, serotonin and
the release substances were not changed. (Figs.
2 and 3)
Promethazine, in the dosage used, had no effect
on the size of the wheals and flares or on the
intensity of bluing following any of the test
injections.
Tripelennamine hydrochloride produced the
following results: The reactions to the release
substances were not altered. Serotonin responses
were markedly suppressed while whealing and
bluing after histamine testing was partially but
not uniformly inhibited.
The treatment with corticosteroids in no way
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FIG. 4. Compound 48-SO iontophoresis (right
side of the picture) abolished the reactions to
intradermal injections of compound 48-80, and
moderately inhibited the reactions to histamine
phosphate.
FIG. 5. Polymixine B sulphate iontophoresis(right side of the picture): marked inhibition of
the reactions to compound 48-80, no influence ou
the reactions to histamine phosphate.
FIG. 6. Polymixine B sulphate iontophoresis(right side of the picture) did not alter the reac-
tions to intradermal trypsin, but completely
abolished those to serotonin.
decreased the intensity of the skin responses to
the test substances.
3. Effect of iontophoretic application of drugs
injections of the test substances. Not listed in the
table is the effect of procaine hydrochloride and
of metanium. The iontophoresis of the former
caused erythema and local anaesthesia, but the
intensity of the bluing remained the same.
Jontophoresis of metanium from the cathode
had no effect; however applied from the anode, it
caused a very marked suppression of the serotonin
reactions, while the histamine responses remained
unaffected.
After one single iontophoretie application of
the histamine release substances the reactions to
the intradermal test injections remained in-
hibited for 24 hours. Forty-eight hours after
completion of the iontophoresis the bluing re-
spouses began to reappear gradually. Triple
iontophoresis of these substances did not prolong
substantially the duration of the above mentioned
inhibition. Single iontophoresis of the histamine
releasers, however, did not result in an even and
uniform depletion of histamine in the treated
FIG. 7. Histamine phosphate iontophoresis(right side of the picture) resulted in complete
elmination of the reactions provoced by intra-
dermal injections of polymixine B sulphate, and in
a very marked inhibition of the reactions to intra-
dermal injections of histamine phosphate.
Table I shows the effect of iontophoretic
application of the various substances on the
bluing response produced by the intradermal
FIG. 8. Histamine phosphate iontophoresis(right side of the picture) did not alter the flares,
wheals, bluing provoced by intradermal serotonin.
'4;
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area, as evidenced by the patchy bluing shown in
pictures No. 16 and 17. Triple iontophoresis made
the depletion more complete and uniform.
Histamine phosphate, given in one single
iontophoretie application, reduced the intensity
of the skin reactions for a short period (less than
24 hours).
The degree of the inhibition produced by the
iontophoresis of the anti-histaminics and of
metanium was the same whether a single or a
triple application was used, but the inhibition
after the former lasted less than 24 hours, while
the effect after triple application lasted over 48
hours.
Bluing Responses to lontophoresis at the Site
of the Electrodes
in one series of experiments a specially shaped
electrode (cross and half cross) was selected and
the coomassie blue was given at the start of the
Fro. 9. Cyproheptadine, 0.2% solution in water,
iontophorised from the anode (right side of the
picture) very markedly inhibited the whealing
and bluing responses provoced by intradermal
compound 48-80, but had no inflnenee on those
provoced by trypsin.
Fm. 10. Promethazine iontophoresis (1.0%
solution in water, from the anode, given on the
right side of the back) completely abolished the
action of intradermal histamine phosphate and of
serotonin.
Fm 14. Extravasation of Coomassie Blue pro-
voced by the iontophoresis of a 0.1% solution of
compound 48—80 in water, from the anode. Picture
taken 2 hours following the ionisation.
Fm. 15. Extravasation of coomassie blue pro-
duced by the iontohoresis of polymixine B sul-
phate (0.2% solotion from the anode). Picture
taken 1 hour after completion of iontophoresis.
iontophoresis. 'the electrode site showed im-
mediate intensive bluing when histamine was
iontophorised. Compound 48-80 gave rise to
bluing of a lesser degree, and least bluing oc-
curred with polymyxin.
These results were obtained when these com-
pounds were applied from the anode, but not
when applied from the cathode. No bluing of the
electrode site cccurred with iontophorcsis of
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promethazine, cyproheptadine, metanium, so-
dium chloride (from either anode or cathode).
(Figs. 13, 14, 15, 16)
An additional observation on a patient with
marked cold urtiearia is recorded. A piece of ice
was applied for 2 minutes to the left forearm and
eoomassie blue was injected intravenously into
the right arm, resulting in marked bluing of the
wheal provoked by the ice application. The
patient was then put on cyproheptadin and the
experiment was repeated. Both whealing and
bluing were markedly suppressed. (Figs. 17, 18)
DTseUssIoN
Intradermal injections of histamine and of
histamine liberators, of serotonin and of trypsin
cause an increase in the permeability of the
capillary wall, which within the limits of our
experiments, appeared to be proportionate to the
type and to the amount of the injected substance.
If the increase in vascular permeability is of a
degree sufficient to permit leakage of plasma
proteins, it can be demonstrated by the indicator
dye. If water and electrolytes only escape, wheal
formation still occurs but the discoloration is
absent. The onset of protein leakage immediately
follows the trauma, in our experiments the
intradermal test injections; it is of short duration,
varying between 5 and 30 minutes, depending on
the type and amount of test material injected. (8)
The use of serial dilutions of the test substances
permitted a more accurate quantitation and
repeated tests gave identical results in the same
persons. Reproducibility of results made this
method suitable for measuring and comparing the
effects of drugs with antihistaminie properties.
Two well known antihistaminie drugs, pro-
methazine and trypelennamine were chosen as
well as cyproheptadine, an experimental sub-
stance with anti-serotonin and anti-histaminie
activity. Given orally in moderate therapeutic
doses, only the last drug led to a suppression of
the whealing responses and the capillary damage
demonstrated by the bluing reaction, following
the intradermal injections of histamine serotonin
and the release substances. Promethazine did not
influence any of the reactions and trypelennamine
showed only minor alterations. This was a sur-
prising finding since both trypelennamine and
promethazine have a potent antihistaminie
effect, established in animal experiments and by
clinical trials. The failure of these two drugs, when
taken orally, to protect the capillaries against
the action of locally injected histamine, is prob-
ably due to an insufficient tissue concentration
at the site of injury. This supposition is borne out
of the fact that the iontophoretie application of
promethazine resulted in a complete suppression
of the reactions to histamine and the release
snbstanees, presumably because a higher tissue
concentration was achieved by this method. As
was to be expected from its oral effectiveness,
iontophoretic introduction of eyproheptadine
showed a similar inhibition. It is of interest to
note that the usual therapeutic dose of pro-
methazine taken by mouth, is 100 to 150 mgms
per day, while cyproheptadine is effective in a
dosage of 4 mgms per day. Thus, given by mouth,
eyproheptadine is effective in a dosage 30 times
smaller than that of promethazine. When how-
ever these two drugs were introduced by ionto-
phoresis, the dose relation was only 1:5 which
may be due to either a better penetration of
promethazine by ionization, or due to a selective
uptake of eyproheptadine by the skin, if given
by mouth. Further experiments will be necessary
to elucidate this point. It should be emphasized
that neither oral nor eleetrophoretie application
of any of the drugs tested influenced the size of
the flares surrounding the wheals, demonstrating
that these drugs do not affect the action of
histamine on the axon reflex.
The failure of the steroids even if given in
high dosage and over prolonged periods of time,
to prevent the capillary damage caused by
histamine was not unexpected since it is known
that these compounds do not block the whealing
effect of injected histamine. On the other hand,
it is thought that steroids inhibit histamine
synthesis, yet in our experiments no altered
responses to the histamine releasers were noted;
perhaps the duration of steroid therapy had been
too short to produce a lowering of the tissue
histamine content.
lontophoretie application was also chosen for
the introduction of the histamine release sub-
stances into the skin, because this method ensures
a high and even tissue concentration of all sub-
stances carrying an electric charge without caus-
ing a trauma, as injections are prone to do. The
successful penetration of these histamine li-
berators and of histamine phosphate, was demon-
strated by the intravenous injection of coomassie
blue while the iontophoresis was in progress.
Intensive bluing of the electrode site occurred
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when histamine was iontophorized, while com-
pound 48-80 and polymyxin showed bluing of a
lesser degree. There was good agreement of these
results with the degree of bluing observed after
intradermal injection of the same substances.
The same experiment was also done with 2%
sodium chloride, as control, and with cypro-
heptadin and promethazine, because some anti-
histaminic substances are known to liberate
histamine if injected into the skin. None of these
substances caused any increase in capillary
permeability and no trace of bluing was seen.
It is known that repeated trauma depletes the
skin of histamine and that urticarial dermo-
graphisme cannot be elicited in the depleted areas.
Restoration of histamine content of the skin
after depletion requires several days. A large
number of chemicals also release histamine from
the tissues and 48-80 and polymyxin are among
the most potent release substances.
lontophoresis of compound 48-80 markedly
diminished the effect of subsequent intradermal
injections of the same compound as well as that
of scrotonin, polymyxin and also of histamine
phosphate. lontophoretic application of poly-
myxin B. gave comparable though weaker in-
hibitions. While it was expected that depletion of
histamine would abolish the effect of subsequently
introduced histamine liberating substances, the
observation that the reactions to histamine
injections into these areas were also markedly
reduced as compared with the control areas,
requires additional explanation. Wilhelm et at. (9)
observed a diminished response to histamine in
rats pretreated with high doses of compound
48-80 given intrapcritoneally. These authors
attributed this result to an non-specific toxic or
debilitating effect of the 48-80 therapy. This,
however, does not apply to our experiments
where only minimal doses of 48-80 were given
locally. Also, the testing with trypsin injections
showed no diminished responses in the ionto-
phorized area. It is suggested that the ionto-
phorctie application of histamine phosphate
caused release of histamine from the tissues and
the commonly seen whealing effect of intra-
dermally introduced histamine may be due not
only to the direct action of the injected material,
but also to liberation of tissue histamine, or in
other words, histamine phosphate acted in our
experiments similar to the histamine release
substances used (14). The cross-experiment,
namely iontophorcsis of histamine phosphate
and subsequent injection of histamine release
substances also showed inhibition of whcaling
and bluing responses, though to a lesser extent
than that seen after iontophores with compound
48-80 and with polymyxin. The outcome of this
experiment seems to support the thesis that
histamine itself acts as a weak histamine releaser.
Compound 48-80 is known to release serotonin
from the mast cells of some animal species,
(besides histamine and heparin) but the scrotonin
content of human mast cells and of the human
skin is probably negligible. lontophoresis of
compound 48-80 and of polymyxin B resulted in a
diminished reaction of subsequently injected
scrotonin, suggesting that bluing after serotonin
injections into human skin is probably also due
to histamine release (13). We can offer no ex-
planation, however, why intradcrmal scrotonin
injections remained unaltered after histamine
iontophorcsis. Further experiments will have to
be done to investigate in more detail the role of
scrotonin and the action of scrotonin inhibitors
and the effect of other vaso-active substances
and their inhibitors. Clcndcnning and Stough-
ton (10) observed no whealing response after
serotonin injections in human skin and Dcmis
and Davies (11) using Evans blue, saw no
staining of the serotonin injections, while IV[oller
and Rorsman (12), using sodium fluoresccin,
observed fluorescence of serotonin wheals in
ultraviolet light. They state that the exudatory
effect of serotonin is about 1000 times weaker
than that of histamine; precisely the same rela-
tion was found in our experiments, comparing
the minimal effective doses by weight.
The reactions of the intradcrmally injected
trypsin were in no way affected by any of the
drugs used either orally or locally, thus confirm-
ing that its action is different from that of any
other test substances in our experiments, and
that it does not involve histamine or its release
in any significant degree. We included trypsin to
investigate whether injections or iontophorcsis of
histamine and other permeability increasing
substances may cause a state of fatigue or lack
of responsiveness of the capillaries. No evidence
of such a mechanism was suggested by our trials.
Most antihistaminie drugs exhibit some local
anesthetic action. lontophorcsis with procain
hydrochloride was therefore used, to see whether
a local anesthetic agent without any significant
effect on the histamine mechanism may alter
skin responses. No such effect was observed.
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Metanium was included in our series to in-
vestigate whether the "bluing" method would
permit a differentiation between the efficacy of
positively and negatively charged parts of a
compound preparation. The alleged anti-inflam-
matory effect of this preparation appears to be
due to the titanium ion since application from
the anode markedly inhibited serotonin reactions.
Mill (15) has demonstrated that salicylates
inhibit responses to histamine and other vaso
active agents but in our experiments the sali-
cylates contained in this product were not
responsible for the inhibitions noted. Sodium
chloride controls were made to rule out the
possible influence of non specific irritation pro-
duced by the iontophoretie procedure itself.
Applied either from the anode or the cathode, no
alterations occurred.
SUMMARY
A new (monazo dye) mono azo, Coomassie Blue,
was used to demonstrate the leakage of plasma
proteins from the capillaries after standardized
trauma induced by intradermal injections of vary-
ing amounts of histamine, histamine release sub-
stances, serotonin and trypsin. The influence of
iontophoretie applications of antihistaminie
drugs, of histamine releasing substances and of
histamine itself on the degree of plasma protein
extravasation was measured and the effect of
systemic therapy with antihistaminic and other
drugs on the intensity of bluing was evaluated.
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